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Edited by Beat ImhofAbstract P-cadherin expression is restricted to the basal layer
of stratiﬁed epithelia including that of the mammary gland.
Although evidence for an important role of P-cadherin in mam-
mary morphogenesis and tumorigenesis is increasing, the mecha-
nisms that regulate its expression are poorly understood. We
show that in basal mammary epithelial cells, b-catenin is associ-
ated with the P-cadherin promoter and activates its expression
independently of LEF/TCF in a cell-type speciﬁc manner.
Down-regulation of endogenous b-catenin levels by RNA inter-
ference technique inhibited P-cadherin promoter activity. In vivo,
in skin and mammary gland of mutant mice, activation of b-cate-
nin signalling correlates with up-regulation of P-cadherin expres-
sion. These data suggest that b-catenin-dependent modulation of
P-cadherin expression can contribute to the establishment of the
basal phenotype.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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P-cadherin promoter1. Introduction
Cadherins are major calcium-dependent cell adhesion mole-
cules involved in morphogenetic and pathological processes
[1,2]. The growing superfamily of cadherins is subdivided into
ﬁve families: classical type I cadherins, atypical type II cadher-
ins, desmosomal cadherins, protocadherins and seven-pass
transmembrane cadherins. Among the classical cadherins, each
member presents a speciﬁc tissue distribution. E- and P-cad-
herin are components of the adherens junctions and are found
in stratiﬁed epithelia such as skin, but E-cadherin is mainly
concentrated in the suprabasal layers and P-cadherin isAbbreviations: a-SMA, a-smooth muscle-actin; K5, keratin 5; K14,
keratin 14; ChIP, chromatin immunoprecipitation
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sion pattern suggests that in addition to maintaining cellular
adhesion, P-cadherin may have other functions in diﬀerentia-
tion and cell growth.
P-cadherin is also found in the basal layer of glandular
pseudo-stratiﬁed epithelia such as the mammary gland. Mam-
mary epithelium comprises a luminal layer of secretory cells
and a basal layer of myoepithelial cells responsible for milk
ejection during lactation. Like other basal epithelial cells,
mammary myoepithelial cells express basal keratins 5 and
14 (K5 and K14), P-cadherin and contractile smooth muscle
proteins such as a-smooth muscle-actin (a-SMA). By con-
trast, luminal cells express keratins 8/18 and E-cadherin.
Myoepithelial cells are in direct contact with the basement
membrane, close to the stroma, and they may participate in
signalling between the epithelial and stromal compartments
of the mammary gland [3].
b-Catenin is a component of adherens junctions where it
directly interacts with the cytoplasmic domain of cadherins.
b-catenin also plays a central role in the intracellular trans-
mission of the Wnt signal, and, together with LEF/TCF tran-
scription factors, it participates in the transactivation of target
genes, including those that encode important regulators of
growth, survival and diﬀerentiation (see Wnt gene home page
at http://www.stanford.edu/~rnusse/pathways/targets.html).
Recently, it has been suggested that Wnt/b-catenin might be
involved in the regulation of P-cadherin expression during
hair bud formation in skin [4]. Importantly, high levels of cell
surface P-cadherin have been detected in hair progenitors cor-
relating with activation of the Wnt/b-catenin pathway [5].
Although several reports suggested that P-cadherin might
play an important role during mammary morphogenesis [6]
and tumorigenesis [7,8] the mechanisms that regulate its
expression are yet poorly understood. The mammary epithelial
cell line BC44 has a ‘‘basal’’ phenotype, with high-level expres-
sion of stratiﬁed epithelia basal cell markers such as K5, K14,
p63 and P-cadherin. We used the BC44 cell line to show that b-
catenin is associated with the P-cadherin promoter in vivo and
stimulates its expression independently of LEF/TCF. Analysis
of P-cadherin expression in mutant mouse tissues conﬁrmed
that b-catenin may modulate transcription of the P-cadherin
gene in stratiﬁed epithelia.blished by Elsevier B.V. All rights reserved.
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2.1. Transgenic mice
K5–DN57–bcat and K14cre/b-cat lox/null transgenic lines were pre-
viously described [9,10].
2.2. Cell lines and transient transfection assays
Culture conditions for BC44 and EpH4 cells were previously de-
scribed [11]. 100.000 cells per well were grown and transfected with
GenePorter Transfection Reagent (Gene Therapy Systems Inc., San
Diego, CA) in 12-well plates following manufacturer’s instructions.
Each well received 250 ng of reporter plasmid, the indicated amounts
of LEF expression plasmids [12] and 250 ng of a stabilized form of
b-catenin lacking the NH2-terminal 57 aminoacids (pCGN–DN57–b-
catenin) [13]. DN57–b-catenin escapes the degradation machinery since
it cannot be phosphorylated by GSK3b kinase and is accumulated in
the nucleus inducing a constitutive signal [13]. TK-Renilla was used
to monitor transfection eﬃciency. Luciferase activities were measured
with the Dual Luciferase Reporter Assay System (Promega, Madison,
WI). At least three independent experiments were performed in dupli-
cate in each case.
For b-catenin RNA interference, two diﬀerent speciﬁc sequences
cloned in the pSuperior vector (Shbcat1: CTGTTGTGGTTAAACT-
CCT; Shbcat2: ACCCTGAGGAAGAAGATGT), kindly provided
by Dr. Peinado (IIB, Madrid, Spain) were used. Two-hundred and ﬁfty
and ﬁve hundred nanograms of a mixture of both plasmids were co-Fig. 1. b-Catenin induces P-cadherin promoter activity in BC44 cells. (A) Sch
LEF/TCF binding sites; open box, GC-rich region; ﬁlled box, CAAT box; ar
immunoﬂuorescence. Bar, 20 lm. (C) Quantitative Northern blot analysis of
of P-cadherin in BC44 cells. b-Tubulin was used as loading control. (E) Eﬀe
were transiently transfected with the complete (1060 bp) P-cadherin promoter
catenin. An arbitrary value of 1 corresponds to the activity of the P-cadheritransfected with P-cadherin promoter and luciferase activities were
measured after 48 h of transfection. Reduction of b-catenin levels
was monitored by co-transfection of pEGFP plasmid together with
Shbcat1 and Shbcat2, followed by immunoﬂuorescence analysis.2.3. Band-shift assay
LEF-1 was produced from a pCIneo expression construct (kindly
provided by A. Benz’ev, Weissman Institute, Rehovot, Israel) with a
coupled transcription and translation kit (Promega). The recombinant
GST/b-catenin fusion protein was puriﬁed from lysates of E. coli trans-
formed with pGEX5-b-cat. Band-shift assays were performed as previ-
ously described [12]. For supershift assays, 1 lg of rat anti-LEF1 (a gift
from Dr. Grosschedl, Max-Plank-Institute, Freiburg, Germany) was
incubated with the mixture before adding the labelled probe.
2.4. Chromatin immunoprecipitation
Immunoprecipitation experiments with an anti-b-catenin antibody
(Santa Cruz Biotech., CA) to examine protein–DNA interactions were
done using the chromatin immunoprecipitation (ChIP) assay kit
(Upstate, Charlottesville, VA) following manufacturer’s instructions.
2.5. Northern blotting
Total RNA was isolated from 107 cells using RNA-plus reagent
(Bioprobe Systems, Montreuil-Sous-Bois, France). Northern blots
were done as previously described [11].ematic diagram of the mouse P-cadherin promoter. P1 and P2, putative
row, transcription start. (B) Localization of b-catenin in BC44 cells by
P-cadherin transcript levels in BC44 cells. (D) Immunoblotting analysis
ct of b-catenin on P-cadherin promoter activity. BC44 and EpH4 cells
construct containing the luciferase gene in the presence or absence of b-
n promoter in the absence of b-catenin.
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RNA extraction from epilated skin or from thoracic mammary
glands and real-time RT-PCR were performed as described [9]. Two
independent experiments were done in duplicate in each case. Gene
speciﬁc primers used for ampliﬁcation are as follows:
Pcad-s: 5 0-ACGAAGCCCCTGTGTTTGTT-3 0;
Pcad-as: 5 0-GTCCTGTGCGGTATAGATGC-3 0
K14-s: 5 0-CGGCAAGAGTGAGATTTCTG-30
K14-as: 5 0-TCCAGCAGGATTTTGTACTC-3 0
a-SMA-s: 5 0-GACCCAGATTATGTTTGAGAC-3 0
a-SMA-as: 5 0-GTCCAGCACAATACCAGTTG-3 0
2.7. Immunoﬂuorescence
Cells plated on glass coverslips and 7 lm cryosections were ﬁxed
with methanol at 20 C for 10 min. The following primary antibodies
were used: anti-b-catenin (BD Transduction Lab. San Diego, CA),
anti-P-cadherin (Takara, Kyoto, Japan) and anti-K5 (Covence, Berke-
ley, CA).
2.8. Immunoblotting
Forty micrograms of RIPA protein extracts from BC44 cells were
analysed by immunoblotting using antibodies against P-cadherin (Ta-
kara) and b-tubulin (Sigma–Aldrich, Saint Quentin Fallavier, France).Fig. 2. LEF/b-catenin complexes bind to the P-cadherin promoter
in vitro. 32P labelled probes containing the consensus LEF-1 sequence
(LEF-1) or the putative LEF/TCF sites of the P-cadherin promoter (P1
and P2) were incubated with puriﬁed LEF-1 factor and analyzed by
band-shift assay in the absence or presence of puriﬁed b-catenin and an
anti-LEF-1 antibody as indicated.3. Results
3.1. High P-cadherin expression level in basal mammary
epithelial cells correlates with b-catenin nuclear localization
The in silico analysis of the mouse P-cadherin promoter
revealed the existence of two putative LEF/TCF binding sites
(Fig. 1A), suggesting the possible involvement of b-catenin/
LEF in the regulation of the P-cadherin promoter.
Basal mammary epithelial cells BC44 express high levels of
P-cadherin [11]. Using immunoﬂuorescence techniques, we
noticed that in sparse BC44 cultures, b-catenin was localized
in the cell nuclei, whereas at conﬂuence, it was concentrated
at cell–cell contact sites (Fig. 1B). Northern blotting analysis
done with RNA isolated from BC44 cells at diﬀerent culture
times demonstrated that P-cadherin expression levels were
highest in sparse cultures, correlating with b-catenin nuclear
localization. When b-catenin moved to the plasma membrane,
P-cadherin mRNA levels also decreased progressively to
relatively low levels in a dense 4-day-old culture (Fig. 1C).
Consistently, P-cadherin protein levels appear high at low
density (1–2-day-old culture) and signiﬁcantly decrease with
conﬂuence (3-day-old culture) as shown by Western blot ana-
lysis (Fig. 1D). These data suggested that b-catenin may be
involved in the regulation of P-cadherin expression.
3.2. Mouse P-cadherin promoter is activated by b-catenin in a
cell-type speciﬁc manner
To examine the eﬀect of b-catenin on P-cadherin promoter
activity, a reporter mouse P-cadherin promoter construct [14]
was transfected with or without b-catenin into BC44 cells
(‘‘basal’’ characteristics, high expression of P-cadherin), or
into EpH4 cells (‘‘luminal’’ characteristics, no detectable
expression of P-cadherin). In BC44 cells, b-catenin activated
promoter activity up to eightfold (Fig. 1E). In EpH4 cells how-
ever, there was no signiﬁcant eﬀect of b-catenin on promoter
activity. Thus, b-catenin activated the P-cadherin promoter
in a cell-type speciﬁc manner.
To determine whether b-catenin/LEF complexes could inter-
act with the two LEF/TCF consensus sites we did band-shiftanalysis (Fig. 2). The two LEF/TCF consensus sites P1 and
P2 are at positions 677 and 408 respective to the transcrip-
tion start site, upstream of the minimal P-cadherin promoter
(Fig. 1A). A probe containing the consensus site for the bind-
ing of LEF-1 was used as a positive control. Puriﬁed HA-LEF-
1 bound to the three probes, P1, P2 and control, inducing a
shifted band of similar size. The addition of GST-b-catenin
induced a supershift, indicating the interaction of b-catenin/
LEF-1 complexes with P1 and P2. The interaction of LEF-1
with sites P1 and P2 was inhibited by an anti-LEF-1 antibody,
demonstrating the speciﬁcity of the shifted band. The P1 site
appeared to have a higher aﬃnity for the puriﬁed factors than
the consensus LEF-1 site.
3.3. b-catenin activates P-cadherin promoter in a
LEF/TCF-independent manner
We then transfected BC44 cells with diﬀerent P-cadherin
promoter deletion constructs containing both LEF/TCF bind-
ing sites (1060 construct), only P2 site (560 construct) or
neither binding site (200 and 75 constructs, Fig. 3A). As
shown in Fig. 3B, b-catenin induced 8- to 10-fold activation
of transcription from all the constructs, regardless of the pres-
ence of LEF/TCF binding sites. Further promoter deletion
(25 construct) resulted in a loss of activation by b-catenin
indicating that in the 75 construct, the elements responsive
to b-catenin are located upstream to 25 position. No signif-
icant eﬀect of b-catenin on the activity of the deletion con-
structs was detected in EpH4 cells (not shown).
These results suggested that b-catenin activated the P-cad-
herin promoter independently of LEF/TCF factors. Consistent
with this conclusion, co-transfection of BC44 cells with b-cate-
nin and increasing amounts of a LEF-1 expression vector did
not further stimulate promoter activity (Fig. 3C). Moreover,
high amounts of LEF-1 inhibited the activation induced by
Fig. 3. b-Catenin activates P-cadherin promoter independently of LEF/TCF transcription factors. (A) P-cadherin promoter deletion constructs. (B)
Eﬀect of b-catenin on the activity of the P-cadherin deletion constructs transiently transfected in BC44 cells. (C) Co-transfection of the P-cadherin
promoter (1060 and 200 constructs) with b-catenin and diﬀerent amounts of LEF-1 in BC44 cells. (D) Co-transfection of the P-cadherin promoter
(1060 and 200 constructs) with increasing amounts of VP16-LEF-1 in BC44 cells. In B, C and D the data are presented as the fold activation in
promoter activity induced by b-catenin (mean + S.D.). Topﬂash reporter activity was the positive control. (E) b-Catenin detection in BC44 cells
transfected with shbcat and pEGFP (immunoﬂuorescence analysis). (F) Co-transfection of the P-cadherin promoter (75 construct) with shbcat or
control shEGFP vectors. The data are presented as Relative Ligth Units (Luciferase/Renilla activity, mean + S.D.).
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dependent activation of the Topﬂash reporter in a dose-depen-
dent manner. The expression of VP16-LEF-1, a fusion protein
able to induce transcription from LEF/TCF sites indepen-
dently of b-catenin, did not activate transcription from the
P-cadherin promoter constructs, whereas Topﬂash reporter
activity was induced by VP16-LEF-1 in a dose-dependent
manner (Fig. 3D). As expected, LEF-1 or VP16-LEF-1 expres-
sion did not activate pxp-25 construct (not shown). Thus, acti-
vation of the P-cadherin promoter by b-catenin is independent
of LEF/TCF factors. The inhibitory eﬀect observed at high
concentrations suggested that LEF-1 could sequester b-cate-
nin, preventing its interaction with other cofactors that con-
tribute to promoter activation.
3.4. Decrease of endogenous b-catenin levels by RNA
interference inhibits P-cadherin promoter activity
To further conﬁrm the involvement of b-catenin in the reg-
ulation of the P-cadherin promoter, we used RNA interference
technique to reduce the endogenous b-catenin levels. As shown
in Fig. 3E, BC44 cells transfected with a mixture of two diﬀer-
ent interference plasmids (shbcat1 and shbcat2) presented re-duced levels of b-catenin compared to adjacent untransfected
control cells. Consistently, transfection of shbcat1 and shbcat2
plasmids inhibited the activity of the P-cadherin promoter up
to 50%, in a dose-dependent manner, while a shEGFP plasmid
used as a control, did not signiﬁcantly alter promoter activity
(Fig. 3F). These results indicate that the endogenous b-catenin
is required for P-cadherin promoter activity in BC44 cells.
3.5. b-Catenin interacts with P-cadherin promoter in BC44 cells
Taken together, these data suggested that b-catenin acti-
vated P-cadherin expression through responsive element(s)
located in the proximal promoter included in the 75 con-
struct. To examine whether b-catenin interacts with the endog-
enous P-cadherin promoter in BC44 cells, we performed
chromatin immunoprecipitation using anti-b-catenin. We
detected a speciﬁc band after PCR on the BC44 immunopre-
cipitate with oligonucleotides corresponding to the 67 to
+87 P-cadherin promoter region. This band was absent if con-
trol non-relevant IgGs were added to the immunoprecipitation
mixture instead of anti-b-catenin antibody (Fig. 4A). An up-
stream region (1020 to 905) of the P-cadherin promoter
was not ampliﬁed in the immunoprecipitate obtained with
Fig. 4. b-Catenin interacts with P-cadherin promoter in BC44 cells.
ChIP assays with an anti-b-catenin or a control IgG antibody were
performed on EpH4 and BC44 cell extracts. PCR products resulting
from the ampliﬁcation of the 67 to +87 promoter region (A) and the
upstream 1020 to 905 region (B) are shown. Products of the input
reactions are presented as positive controls for PCR.
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obtained with the P-cadherin reporter constructs, no band
was ampliﬁed in the b-catenin immunoprecipitate from
EpH4 cells presenting luminal phenotype and, thus, negative
for P-cadherin. These results demonstrate that in BC44,
expressing high levels of P-cadherin, b-catenin is associated
with the P-cadherin promoter.
3.6. Activation of b-catenin signalling correlates with
up-regulation of P-cadherin expression in vivo
We next studied whether b-catenin aﬀects P-cadherin expres-
sion in vivo, in mutant mouse tissues. We used quantitative
RT-PCR to analyze the expression of P-cadherin in skin from
transgenic mice expressing stabilized (N-terminally truncated)
b-catenin under the control of the K5 promoter, which is
active in basal cells from stratiﬁed epithelia (K5–DN57–bcat
transgenic mouse line) [9]. In transgenic mouse skin, relative
levels of P-cadherin were 2.7-fold higher than in wild-type mice
of the same age (Fig. 5A), suggesting that the constitutive acti-Fig. 5. P-cadherin expression in mouse skin and mammary gland. (A–C) Real
12-month-old K5–DN57–bcat mice and wild-type littermates; (B) skin from
littermates; (C) mammary glands from 12-month-old K5–DN57–bcat mice a
were analyzed in each case. Mean values normalized to the K14 or to th
transgenic and wild-type animals was statistically signiﬁcant (A P < 0.004; B
K5–DN57–bcat mammary glands. Double immunoﬂuorescence analysis of a
DN57–bcat mouse done with anti-P-cadherin and anti-K5 antibodies. Bar, 4vation of b-catenin signalling resulted in up-regulation of P-
cadherin expression. In mouse skin depleted of b-catenin
[10], P-cadherin mRNA levels were 2.4-fold lower than in
wild-type littermate skin (Fig. 5B), indicating that P-cadherin
expression was down-regulated in the absence of b-catenin.
Next, we analyzed P-cadherin expression in the mammary
glands of K5–DN57–bcat females. In these mice, constitutive
activation of b-catenin signalling leads to the development of
mammary hyperplastic lesions comprising undiﬀerentiated
basal cells [9]. Staining with anti-P-cadherin antibody showed
high levels of P-cadherin expression in the hyperplasic areas
of K5–DN57–bcat mouse mammary glands (Fig. 5D). Com-
parison of P-cadherin expression in tumour-free areas of
K5–DN57–bcat mammary glands to that in wild-type glands
using quantitative RT-PCR revealed a moderate but statisti-
cally signiﬁcant increase of P-cadherin expression in transgenic
mouse tissue (Fig. 5C). Basal keratin (K5 and K14) expression
levels were higher in the mammary glands of K5–DN57–bcat
mice than in controls; therefore, in these experiments, a-
SMA, another marker of basal myoepithelial cells, was used
to normalize P-cadherin transcript levels. Altogether these re-
sults clearly indicate that b-catenin participates in the control
of P-cadherin expression in vivo.4. Discussion
Similar to other stratiﬁed or pseudo-stratiﬁed epithelia, the
two layers of mammary epithelium have a diﬀerential pattern
of E- and P-cadherin expression. E-cadherin is concentrated
in luminal cells, but is hardly detected in basal myoepithelial-time RT-PCR analysis of P-cadherin transcript levels in: (A) skin from
1-month-old mice conditionally ablated for b-catenin and wild-type
nd wild-type littermates. Three wild-type and four transgenic animals
e a-SMA mRNA levels ± S.E.M. are shown. The diﬀerence between
P < 0.005; and C P < 0.02). (D) P-cadherin detection in wild-type and
wild-type mouse mammary duct and a mammary hyperplasia of a K5–
0 lm.
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[15]. Down-regulation of E-cadherin promoter activity by a
Wnt signal has been reported [4]. Our results show that P-cad-
herin promoter activity is up-regulated by b-catenin support-
ing the hypothesis that a unique signal provided by Wnt/
b-catenin induces the switch from E- to P-cadherin expression
in the basal layer of stratiﬁed epithelia.
We have found that P-cadherin promoter activation by b-
catenin is independent on LEF/TCF factors. In agreement
with this result, P-cadherin expression is not aﬀected in a
LEF1-null background [4]. Although most known b-catenin
target genes require LEF/TCF for their activation [16], several
studies reported that b-catenin could activate transcription
independently of LEF/TCF but in concert with other tran-
scription factors [17–19]. However, the P-cadherin promoter
fragment activated by b-catenin does not contain consensus se-
quences corresponding to putative binding sites for known b-
catenin cofactors, making their involvement unlikely.
The nature of cofactors involved in the b-catenin-dependent
activation of the P-cadherin promoter remains to be deter-
mined. Our data indicate that, at least, some of the elements
responsive to the activation by b-catenin are located in the
75 to 25 promoter region. Putative binding sites for AP2
and Ets-1 factors are present in this region. However, their
co-expression with b-catenin did not lead to any signiﬁcant in-
crease in activation levels attained in the presence of b-catenin
(not shown).
The possible involvement of p63 transcription factor in the
regulation of the P-cadherin promoter represents an attractive
hypothesis since in vivo p63 is co-expressed with P-cadherin in
basal layer of stratiﬁed and pseudo-stratiﬁed epithelia. An
imperfect putative p63 site is found at position 43 in the P-
cadherin promoter. Further work is required to determine
whether p63 contributes to the activation of the P-cadherin
promoter by b-catenin.
Recent studies using gene array technology have revealed a
subset of mammary carcinomas characterized by expression
of basal cell markers and associated with a particularly poor
clinical outcome [20]. Therefore, it is important to identify
the molecular mechanisms that control the expression of the
set of the basal epithelial cell markers. Here we show that
the expression of the basal marker P-cadherin is controlled
by the b-catenin pathway. In agreement with our data, tran-
scriptional proﬁling of human breast cell lines has identiﬁed
numerous Wnt/b-catenin target genes as markers of a ‘‘basal’’
phenotype [21], indicating that Wnt/b-catenin signalling may
be an important factor in the acquisition and maintenance of
basal phenotype in normal tissue and in disease.
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